-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KyWkYrXr505a94eemQFe8i1LagApAmHVPwp90JivKSCOheDFyW4cQBdD6e3TFQZV /4x10L2LDOqwmNf3S8jXJA== 0000109657-06-000077.txt : 20061108 0000109657-06-000077.hdr.sgml : 20061108 20061108150533 ACCESSION NUMBER: 0000109657-06-000077 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061106 FILED AS OF DATE: 20061108 DATE AS OF CHANGE: 20061108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OXIS INTERNATIONAL INC CENTRAL INDEX KEY: 0000109657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 941620407 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 323 VINTAGE PARK DRIVE, SUITE B CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6502122568 MAIL ADDRESS: STREET 1: 323 VINTAGE PARK DRIVE, SUITE B CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/ DATE OF NAME CHANGE: 19850312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: REPINE JOHN E CENTRAL INDEX KEY: 0001067191 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-08092 FILM NUMBER: 061197101 BUSINESS ADDRESS: BUSINESS PHONE: 3036501200 MAIL ADDRESS: STREET 1: 6850 N BROADWAY SUITE G CITY: DENVER STATE: CO ZIP: 80221 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2006-11-06 0 0000109657 OXIS INTERNATIONAL INC OXIS.OB 0001067191 REPINE JOHN E 70 CHERRY HILLS FARM DRIVE ENGLEWOOD CO 80113 1 0 0 0 Common Stock 2006-11-06 4 A 0 50000 0.18 A 50000 D Non-Qualified Stock Option (right to buy) 0.2 2006-11-06 4 A 0 200000 0 A 2007-01-15 2016-11-05 Common Stock 200000 277187 D Non-Qualified Stock Option (right to buy) 0.2 2006-11-06 4 A 0 200000 0 A 2006-11-14 2016-11-05 Common Stock 200000 477187 D Pursuant to the terms of a consulting agreement dated November 6, 2006, Dr. Repine was granted discounted shares valued at $9,000. Options granted pursuant to the terms of a consulting agreement dated November 6, 2006. 100,000 options vest in four quarterly installments and 100,000 options vest in eight qauarterly installments commencing January 15, 2007. Options granted pursuant to the terms of a consulting agreement dated November 6, 2006. Options vest in six monthly installments commencing November 14, 2006. Michael D. Centron, attorney-in-fact for John E. Repine 2006-11-08 -----END PRIVACY-ENHANCED MESSAGE-----